Skip to main content

Table 4 Plasma lipid peroxidation, thiols and taurine

From: Oral contraceptives modify DNA methylation and monocyte-derived macrophage function

Type Fs, n = 72 FOCs, n = 67 P value FOCA+, n = 28 FOCA-, n = 39 P value
Malonyldialdehyde (μM) 4.2 ± 1.9, n = 69 4.1 ± 1.7, n = 66 NS 3.7 (1.3 to 8.6), n = 27 3.9 (0.9 to 8.6), n = 39 NS
Homocysteine (μM) 8.7 (4.0 to 41.1) 8.3 (4.3 to 16.7) NS 8.3 ± 2.9 8.9 ± 2.9 NS
Cysteine (μM) 195.6 (118.9 to 350.7) 176.6 (115.8 to 318.4) 0.003 181.5 ± 39.8 186.6 ± 45.4 NS
Cysteinglycine (μM) 18.7 (7.6 to 33.6) 19.5 (7.4 to 38.8) NS 20.6 (11.4 to 38.8) 18.9 (7.4 to 33.0) NS
Glucylcysteine (μM) 4.5 ± 1.0 4.5 ± 0.9 NS 4.4 ± 1.0 4.5 ± 0.9 NS
Glutathione (μM) 7.4 (2.7 to 14.8) 8.0 (3.9 to 14.9) NS 8.0 ± 2.4 8.2 ± 2.0 NS
Taurine (μM) 64.1 (31.7 to 202.7) 59.6 (27.3 to 158.9) NS 60.9 (27.3 to 146.8) 59.4 (36.3 to 158.9) NS
  1. Data are expressed as the mean ± SD or as medians and ranges; n indicates the number of samples used to calculate the statistics.
  2. FOCA+/FOCA- = FOCs further stratified as a function of androgenic (FOCA+) and non-androgenic (FOCA-) properties of progestins; FOCs = women treated with OCs for at least 3 months; Fs = women who had not used OCs for at least 3 months to ensure a sufficient washout period; NS = not significant; OC = oral contraceptive.